Analyst Reco. Stride, Inc.

Equities

LRN

US86333M1080

Market Closed - Nyse Other stock markets 04:00:02 2024-04-23 pm EDT			5-day change	1st Jan Change
58.2 ^USD	+0.17%		+1.09%	-1.97%

Apr. 23	Stride Fiscal Q3 Earnings, Revenue Rise; Fiscal 2024 Guidance Revised	MT
Apr. 23	Transcript : Stride, Inc., Q3 2024 Earnings Call, Apr 23, 2024

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

BMO Capital Adjusts Price Target on Stride to $72 From $71, Keeps Outperform Rating	Jan. 25	MT
Barrington Ups Price Target on Stride to $75 From $70 as Fiscal Q2 Results Surpass Estimates, Maintains Outperform Rating	Jan. 25	MT
Barrington Research Adjusts Stride's Price Target to $75 From $70, Maintains Outperform Rating	Jan. 24	MT
BMO Capital Adjusts Stride's Price Target to $67 From $57, Maintains Outperform Rating	Nov. 16	MT
Morgan Stanley Adjusts Price Target on Stride to $60 From $57, Maintains Equal-Weight Rating	Nov. 16	MT
BMO Capital Raises Price Target on Stride to $57 From $50, Maintains Outperform Rating	23-10-26	MT
Barrington Raises Price Target on Stride to $60 From $50, After Q1/24 Earnings Top Estimates, Maintains Outperform Rating	23-10-25	MT
Morgan Stanley Adjusts Price Target on Stride to $57 From $52, Keeps Equalweight Rating	23-10-25	MT
BMO Capital Adjusts Price Target on Stride to $50 From $49, Maintains Outperform Rating	23-08-16	MT
Morgan Stanley Adjusts Price Target on Stride to $52 From $50, Keeps Equalweight Rating	23-08-16	MT
Morgan Stanley Adjusts Price Target on Stride to $50 From $46, Maintains Equal-Weight Rating	23-04-26	MT
Morgan Stanley Downgrades Stride to Equal Weight From Overweight, $46 Price Target	23-03-10	MT
ANALYST RECOMMENDATIONS : Admiral, Alaska Air, KeyCorp, SVB Financial, United Airlines...	23-03-10
BMO Capital Raises Stride's Price Target to $48 From $47, Maintains Outperform Rating	23-01-26	MT
Morgan Stanley Adjusts Price Target on Stride to $46 From $41, Maintains Overweight Rating	23-01-25	MT
Morgan Stanley Cuts Price Target on Stride to $41 From $43, Keeps Overweight Rating	23-01-04	MT
BMO Capital Trims Stride's Price Target to $50 From $52, Maintains Outperform Rating	22-10-27	MT
Morgan Stanley Adjusts Stride Price Target to $43 From $47, Maintains Overweight Rating	22-10-26	MT
Morgan Stanley Adjusts Stride's Price Target to $47 from $45, Maintains Overweight Rating	22-09-27	MT
Morgan Stanley Upgrades Stride to Overweight From Equalweight, Maintains $45 Price Target	22-08-25	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Stride, Inc.

Equities

LRN

US86333M1080

Analyst Reco.

Filters